Table 2.
DTC migration defects |
||||||
---|---|---|---|---|---|---|
RNAi method | Target | Genotype | Development | Class-l | Class-s | n |
Injection | mig-6S and L | Wild type | Embryonic/L1 arrest | - | - | |
mig-6S | Wild type | Embryonic/L1 arrest | - | - | ||
mig-6L | Wild type | Normal | 100% | - | >100 | |
Feeding | mig-6S and L | Wild type | Normal | 100% | - | >100 |
mig-6S | Wild type | Normal | 0% | 0%(A), 6%(P)* | 152 | |
mig-6L | Wild type | Normal | 100% | - | >100 | |
Feeding | mig-6S | rrf-3 | Normal | 0% | 6%(A), 37%(P)† | 63 |
Phase 2V and D defects are predominant.
Phase 2M defect is predominant.